Diabetic Sural Nerve Neuropathy Assessment
Corresponding Organization :
Other organizations : Sumitomo Dainippon Pharma (United States), University Health Network
Protocol cited in 23 other protocols
Variable analysis
- Disease severity stratification based on TCNS
- Performance of the modified TCNS (mTCNS) across the full range of disease severity
- Age (18-70 years)
- Presence of diabetes mellitus
- Sural nerve amplitude response of 1.0 µV or more
- Presence of symmetrical distal DSP as defined by the modified San Antonio Criteria
- Absence of known non-diabetic causes of neuropathy (e.g., vitamin deficiencies, uraemia, thyroid disease, lumbar or cervical radiculopathy, inflammatory neuropathy, alcoholism)
- Patients with known non-diabetic causes of neuropathy
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!